A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation
Phase: NA
Conditions: Pain Management
Sponsor: The University of Texas Health Science Center, Houston

1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A non-invasive intervention (BreEStim) for management of phantom limb pain (PLP) after limb 
amputation 
 
NCT04751526 
 
Version Date:12/03/2020  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

2 
 
cacy, such 
 
 
University of Texas Health Science Center at Houston/Memorial Hermann Healthcare System 
 
 
A non-invasive intervention (BreEStim) for management of phantom 
limb pain (PLP) after limb amputation 
Protocol (CPHS HSC-MS-20-1032) 
 
1. Protocol Title: A non-invasive intervention (BreEStim) for management of phantom limb pain 
(PLP) after limb amputation 
PI: Sheng Li, MD, PhD 
Co-Investigators: Daniel Melton, MD; Shengai Li, MS 
Study Coordinator: not identified 
Population: amputee subjects 
Number of Sites: single site 
Study Duration: planned for 3 years 
Subject Duration: estimated 64 subjects 
 
2. Specific aims and research questions: 
 
The overall goal of this project is to compare the effectiveness of innovative intervention of breathing- 
controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in 
management of neuropathic phantom limb pain in patients after limb amputation. 
 
3. Background/literature review, Justification and Significance: 
 
a) Importance of the problem 
1) The need and target population 
In the United States, there are approximately 1.7 million people living with limb loss(Ziegler- 
Graham et al. 2008). It is estimated that one out of every 200 people in the U.S. has had an 
amputation(Adams et al. 1999). Limb amputation could lead to three non-exclusive phenomena, 
including phantom limb pain (painful sensation from the absent limb, i.e., phantom limb), phantom 
limb sensation (any sensation in the absent limb, except pain), and stump pain (pain localized in the 
residual limb) (Nikolajsen and Jensen 2001). Phantom limb pain (PLP) is a complex condition that is 
caused by peripheral nerve damage from amputation. Similar to neuropathic pain from other 
etiologies (e.g., spinal cord injury), PLP is characterized by spontaneous and ongoing pain, described 
as burning, shooting, prickling or electrical, and/or pain in response to innocuous stimuli (allodynia) 
and exaggerated pain in response to noxious stimuli (hyperalgesia) (Bennett 2010). PLP has 
increasingly been recognized as an important contributor to suffering, poor rehabilitation outcomes, 
reduced quality of life, and employment status of the persons with PLP after amputation. This is 
because of the following facts. 
• 
PLP is very common(Werhagen et al. 2004). About 60-80% amputees have PLP at 2 years post- 
amputation (Jensen et al. 1985; Ephraim et al. 2005). 
• 
PLP does not resolve over time. Phantom pain does not change after 6 months post-amputation 
(Jensen et al. 1985). 
• 
PLP is difficult to manage (Woolf and Mannion 1999). Currently, pharmacological management is 
the standard of care for PLP. According to a Cochrane review(Alviar et al. 2011), there are 6 
groups of medications with different pharmacological mechanisms have bIReeBnNuUsMeBd.ESR:oHmSeC-MS-20-1032 
medications demonstrated trends in short-term analgesic effi 
aIsRBgaAbPaPpReOnVtiAnLanDdATE: 12/03/2020 

IRB APPROVAL DATE: 12/03/2020 
2 
 
morphine. But the studies lacked long-term efficacy and safety outcomes. Furthermore, more 
studies were not specifically for PLP(Hall and Eldabe 2018). Nevertheless, pharmacological 
interventions are often associated with side effects, such as addiction, withdrawal, and 
constipation, etc. 
• 
PLP is related to poorer physical, psychological and social functioning(Stormer et al. 1997; 
Norrbrink Budh et al. 2005; Jensen et al. 2007); More importantly, it was found that employment 
status was related to the intensity of PLP. Unemployed amputees reported higher levels of PLP 
and lower levels of prosthesis use(Whyte and Carroll 2002). 
• 
These challenges in treating neuropathic PLP likely contribute to opioid overuse and the opioid 
epidemics(Manchikanti et al. 2012). The U.S. Senate passed the Comprehensive addition and 
Recovery Act (CARA), which takes incremental steps to combat the epidemic. It was signed into 
law in July 2016(CARA 2016). To combat this epidemic and to help manage PLP in particular, it 
is critically important to develop non-pharmacological interventions. 
Alternative, non-pharmacological treatments have been tried for management of neuropathic pain 
in the target population. Acupuncture and various electrical stimulation techniques have been used 
clinically and have demonstrated some success. Based on our pioneering discovery that human 
voluntary breathing could have systemic effects, including pain reduction(Li and Rymer 2011a), we 
propose an innovative treatment – Breathing-controlled electrical stimulation (BreEStim) for 
neuropathic pain management. Briefly, in the BreEStim treatment, a single-pulse electrical 
stimulation is delivered to peripheral nerve(s) when patients are taking a fast, strong, and deep 
inhalation, similar to a deep breath but faster and stronger. Patients control the intensity of electrical 
stimulation, to increase the intensity as tolerated gradually. As compared to conventional electrical 
stimulation (EStim), this patient-centered treatment of BreEStim increases its analgesic effectiveness 
by integrating various internal coping mechanisms, including voluntary and active involvement of 
patient in their own care, electroacupuncture effect, electrical stimulation effect, neurobehavioral 
modulations (habituation to aversive stimuli, and activation of the reward system), resulting in 
increased pain threshold and pain tolerance (Li et al. 2013). Our pilot data have demonstrated that 
BreEStim has better effectiveness in pain reduction in patients with above-the-knee amputation in our 
previous case report (Li et al. 2012a). 
The proposed research will further compare the effectiveness of BreEStim and EStim in 
management of neuropathic pain in patients with PLP. This well-coordinated clinical study by an 
established scientist-physician team will provide direct evidence of clinical effectiveness of BreEStim 
in phantom limb pain management. As such, an alternative and effective non-pharmacological 
treatment of PLP could be developed. 
 
2) The proposed activities further the purposes of the Act 
The intention of the Rehabilitation Act of 1973 is to promote the right of individuals with 
disabilities. They constitute one of the most disadvantaged groups in society, to live independently, 
contribute to society, pursue meaningful careers, and enjoy full inclusion and integration into all 
aspects of mainstream American society. It ensures that the U.S. government plays a leadership role 
in promoting the employment of individuals with disabilities. 
The proposed project seeks to develop an alternative, noninvasive, and non-pharmacological 
treatment (BreEStim) for phantom limb pain management. Comparisons of analgesic effects between 
BreEStim and conventional electrical stimulation technique (EStim) will demonstrate superior 
analgesic effects by BreEStim. This has been shown in our recent preliminary study using BreEStim 
for neuropathic pain after spinal cord injury(Li et al. 2016; Karri et al. 2018a; Li et al. 2018). With the 
evidence and results to be obtained from this project, we will be able to provide strong clinical and 
laboratory evidence that this treatment will provide more effective and longer lasting analgesic effects 
for these patients, and improve general well-being of these patients. As mentioned earlier, quality of 
life and unemployment status is related to the severity of PLP(Whyte and Carroll 2002). Therefore, 
the proposed activities will obviously benefit a large population of patients, who may experience 
different levels of impairment and disability, by reducing their pain, emotional tension, thereby 
maintaining and enhancing quality of life and employment for these patients and meanwhile reducing 
the burden on caregivers. In this manner, the proposed activity will clearly increase these patients’ 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
3 
 
ch as acup 
ability to achieve the stated mandates of the Rehabilitation Act. The proposed activities, therefore, 
clearly further the goals of the Rehabilitation Act. 
3) The proposed project will have beneficial impact on the target population. 
As mentioned above, neuropathic phantom pain is very common, difficult to manage, and has 
increasingly been recognized as an important contributor to suffering, poor rehabilitation outcomes, 
reduced quality of life and employment status of the persons who are suffering chronic neuropathic 
pain (Stormer et al. 1997; Whyte and Carroll 2002; Norrbrink Budh et al. 2005; Jensen et al. 2007). 
BreEStim integrates multiple pain-coping mechanisms and provides better analgesic effects in 
neuropathic treatment. Our research will provide direct evidence of BreEStim as an effective 
alternative treatment for chronic neuropathic pain in patients suffering from amputation. As such, 
BreEStim could be added as a routine care for these patients. More specifically, the beneficial impact 
of the proposed research on BreEStim for neuropathic pain management can be summarized as 
follows: 
• BreEStim is a non-invasive, non-pharmacological treatment. This is critical because most pain 
medications have side effects, sometimes very severe. These side effects could include 
addiction, overdose, withdrawal symptoms, and constipation, etc. These potential side effects 
could be avoided in the BreEStim treatment. 
• BreEStim provides better analgesic effects. As compared to conventional electrical stimulation 
(EStim), this patient-centered treatment of BreEStim increases its analgesic effectiveness by 
integrating additional coping mechanisms. Patients are able to tolerate high levels of electrical 
stimulation, leading to enhanced analgesic effects. Such a positive feedback loop (activation of 
the reward system) results in a greater clinical efficacy. 
• BreEStim is an alternative choice for PLP management. This alternative non-pharmacological 
treatment with better analgesic effects is important, particularly when PLP is difficult to manage. 
For example, only 7% of responders reported pharmacological treatment is effective for 
neuropathic pain in a postal survey (Finnerup et al. 2001a) 
• BreEStim is patient-centered. As in our pilot study (Li et al. 2012b; Li 2013), patients will feel they 
actively participate in managing their pain, rather than “a passive participant in their own care”. 
This may enhance their treatment compliance on one hand, and psychological function on the 
other hand. Furthermore, BreEStim is specifically tested for this target population. In contrast, 
more studies with pharmacological agents on neuropathic pain are not specifically for PLP (Hall 
and Eldabe 2018). 
 
b) Design of research activities 
A. 
Comprehensive and informed review of the current literature 
• 
Scope of the project and general introduction 
Overall, mechanisms of phantom limb pain are not well understood. Definition of neuropathic pain is 
defined as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory 
system” (Treede et al. 2008). Neuropathic pain can occur secondary to injury to peripheral nerves 
(peripheral neuropathic pain, e.g., amputation) or to spinal cord and brain (central neuropathic pain, e.g., 
post-traumatic headache (PTH) after traumatic brain injury (TBI)). PLP has been viewed as a 
maladaptive response after amputation. Possible mechanisms include ectopic impulse generation and 
transmission after nerve damage, amplification of impulses via peripheral and central sensitization, 
maladaptive changes in descending mechanisms (Costigan et al. 2009). Neuroimaging studies have 
demonstrated that both topographic shifts (Flor et al. 1995) and preserved representations (Makin et al. 
2013) of the former hand area in patients with phantom limb pain. It has been proposed that PLP 
emerges as memory of phantom limb sensation in dynamic overlapping brain networks that is triggered 
and reinforced in the presence of associated distress (De Ridder et al. 2011). 
Management of PLP in general has been a challenge for both physicians and patients. PLP is usually 
chronic and severe, and requires continuous analgesic treatment. The standard of care of PLP 
management is to prescribe pharmacological agents. Six groups of medications with different 
mechanisms of action have been used for PLP management. It is still difficult to draw definitive 
conclusions on efficacy of pharmacological management of PLP with available evidence(Hall and Eldabe 
2018). Other than pharmacological management, there are numerous modalities have been used for 
management of neuropathic pain with some degrees of success, su 
unIRcBtuNreU(MHBuEi Ret: HalS.C2-0M0S0-;20-1032 

IRB APPROVAL DATE: 12/03/2020 
4 
 
t al. 2008).
Han 2004; Yoo et al. 2004; Cho et al. 2006; Dhond et al. 2008) and neuromodulation. Various 
neurostimulation techniques include transcutaneous electrical nerve stimulation (TENS) (Norrbrink Budh 
and Lundeberg 2004), spinal cord stimulation (Finnerup et al. 2001b), deep brain stimulation (Murphy 
and Reid 2001), and transcranial direct current stimulation (tDCS) (Fregni et al. 2006). 
Taken together, it is very difficult to treat PLP. It is likely related to complex underlying 
mechanisms. New conceptualization is needed not only to understand the mechanisms, but also to 
provide a theoretical basis for development of new interventions. In this proposed project, we would like 
to focus on an innovative intervention that has been developed from our pioneering studies on the 
systemic effect of human voluntary breathing and its relation to chronic neuropathic pain. In essence, we 
propose a new theoretic approach, as well as a breakthrough innovative non-pharmacological 
treatment – voluntary breathing controlled electrical stimulation (BreEStim) (Li and Rymer 2011b; 
Li 2013; Li et al. 2013) for management of neuropathic PLP after amputation. The primary goal is to 
examine the effectiveness of BreEStim for PLP management. 
We would like to start our application with a common observation: A 3-year-old girl cries after a fall 
which results in a minor skin abrasion on her right knee. She calms down when being rubbed on her right 
knee by her mom, and stops crying and continues to play when being re-directed to her favorite toy 
(cf.(Von Baeyer 1998)). This scenario exemplifies some features of pain. Pain is a subjective feeling that 
is multi-dimensional. Pain is not only sensory, but also emotional and could trigger behavioral responses 
(affective), e.g., crying. Distraction by re-directing attention does not make the sensation of painful stimuli 
(from knee) go away. However, the child does not feel bothered by the pain (affective aspect) when 
playing her favorite toy. It suggests that sensation (painful stimuli) and affective component of pain are 
two different, but parallel processes. Furthermore, crying may help pain relief. A shrewd observer may 
notice that the inspiratory phase is usually deeper and longer during the pain-induced cry. It suggests 
that effortful inhalation may help ease pain, rather than just emotional expression. 
We will now review the relevant literature 
• 
Different aspects of multi-dimensional pain 
Sensory processing of neuropathic pain Pathways for sensory processing of painful stimuli 
are well documented. From the periphery to the spinal cord, noxious stimuli are primarily conveyed by Aδ 
and C-fibers. These primary afferents enter the CNS via the dorsal roots and terminate mainly in the 
superficial laminae (I and II) of the dorsal horn although they also send collateral projections to deep 
laminae (V, VI, and adjacent VII, and X) of the dorsal horn. Furthermore, the tactile (Aβ) fibers that 
terminate the intermediate (III, and IV) laminae, also send collateral projections to deep laminae (Willis 
and Coggeshall 1991). Noxious stimuli are transmitted in parallel to different subcortical and cortical 
areas, following different pain pathways (Gauriau and Bernard 2002; Bennett 2010), including Spino- 
thalamic projections, Spino-reticular projections, and Spino-parabrachial projections. Following 
transection of peripheral axons after amputation, sprouting occurs at the ventral terminals of the large 
myelinate axons. This sprouting allows the sensory axons to terminate in Lamina II instead of laminae III 
or IV, in other words, “wrong connections”. This may explain why light touch can trigger discomfort or 
even pain. 
Affective processing of neuropathic pain (beyond sensation) Neuroimaging studies have 
consistently demonstrated increased activation in multiple cortical and subcortical areas in response to 
pain. Significant regions of activation during nociceptive stimulation include primary and secondary 
somatosensory cortex, the anterior cingulate cortex, insula, thalamus and prefrontal cortex (Peyron et al. 
2000; Apkarian et al. 2005; Tracey 2005). Recent data from evoked potentials in humans with implanted 
electrodes in several brain structures indicate that painful stimuli are processed in parallel in the 
somatosensory cortex and anterior cingulate cortex (ACC). This suggests that the sensory and affective 
aspects are processed in parallel simultaneously and not serially (Frot et al. 2008). 
Awareness of the noxious stimulus arises when this activity is connected to a larger coactivated 
awareness or perceptual network that involves anterior cingulate cortex (ACC), precuneus, parietal 
cortex, and frontal cortex. In other words, the stimulus becomes conscious only when its appropriate 
neural discriminatory representation in the somatosensory cortices is functionally connected to the 
awareness network. In persistent vegetative state, patients are awake but without awareness and without 
conscious percepts (Laureys 2007). Pain stimuli only activate the thalamus and the primary sensory 
cortex, since the primary sensory cortex is functionally disconnected from the secondary somatosensory 
cortex as well as from the above-mentioned awareness areas (Boly e 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
5 
 
The awareness network, together with the posterior insula, is relevant for integration of sensory 
experience in bodily self-consciousness. Subjective experience of pain emerges when the posterior 
insula triggers the pain network, including the parietal operculum and the midcingulate gyrus (Isnard et 
al. 2011). The leading role of the insula on the affective dimension of pain is further supported by another 
study (Von Leupoldt et al. 2009). When the sensory intensity of experimentally induced pain was rated 
similarly by asthmatic patients with dyspnea and healthy subjects with comparable induced-dyspnea, 
ratings of the affective unpleasantness of pain were reduced in asthmatic patients. This perceptual 
difference was mirrored by reduced insular cortex activity, but increased PAG activity in patients (Von 
Leupoldt et al. 2009). This study suggests that a down-regulation of insular cortex activity secondary to a 
neuronal habituation mechanism after dyspnea in patients with chronic asthma is generalized to reduced 
affective unpleasantness of pain. 
Descending modulation 
Different descending pathways are involved in modulation of pain. 
Descending pathways originated in the ACC, amygdala, and hypothalamus are relayed to the spinal cord 
through brain stem nuclei in the PAG and rostroventral medulla (RVM) (Fields and Basbaum 1999). The 
ACC is thought to encode unpleasantness, i.e., the emotional component of pain and anxiety. The ACC 
exerts top-down influences on the brainstem to gate pain modulation (Jones and Gebhart 1988; 
Calejesan et al. 2000), such as distraction (Valet et al. 2004). The PAG projects to the RVM which in turn 
sends projections to the spinal dorsal horn via the PAG-RVM pathway. Stimulation of either the PAG or 
the RVM produces inhibition of dorsal horn neurons including spinothalamic tract cells. Other common 
descending pathways originate in the reticular system in the RVM and pontine neurons. The reticular 
system uses serotonin as a neurotransmitter. The pontine noradrenergic cell groups use the 
neurotransmitter noradrenaline and produce inhibition of dorsal horn neurons. 
The PAG is widely connected with other cortical and subcortical areas. Diffusion tensor imaging 
(DTI) is an MRI-based technique that can map white matter connections in the living human brain. 
Connections have been identified between the PAG and the prefrontal cortex, amygdala, thalamus, 
hypothalamus and rostroventral medial medulla bilaterally (Lorenz et al. 2003; Valet et al. 2004; 
Hadjipavlou et al. 2006). 
With its wide connections with prefrontal and limbic areas and other subcortical areas, the PAG is 
viewed as the area housing “command neurons” (Iigaya et al. 2010). A recent human study supports the 
important role of the PAG in regulation of both respiration and pain(Von Leupoldt et al. 2009). In this 
study, dyspnea (induced by resistive loaded breathing) and heat pain were induced in both asthmatic 
patients and healthy controls. When the sensory intensity of both dyspnea and pain sensations was 
rated similarly by patients and controls, patients reported less unpleasantness of dyspnea and less pain. 
This perceptual difference was mirrored by reduced insular cortex activity, but increased PAG activity in 
patients during both increased dyspnea and pain. Connectivity analyses showed that asthma-specific 
down-regulation of the insular cortex during dyspnea and pain was moderated by increased PAG activity. 
This study suggests that a neuronal habituation mechanism reducing the affective unpleasantness of 
dyspnea in asthma is able to generalize to other unpleasant physiological sensations such as pain (Von 
Leupoldt et al. 2009). 
The PAG could be maladaptive in response to chronic pain, however. It has been reported that 
the PAG and cingulate cortex were activated significantly less during suppression of pain in patients with 
complex regional pain syndrome I (CRPS I), as compared to healthy controls (Freund et al. 2011). On 
the other hand, increase in neuronal activity in the PAG was found to be the greatest in patients with 
neuropathic pain during anticipation of exercise or actual exercise. These changes were accompanied by 
changes in respiration, blood pressure and heart rate (Green et al. 2007). If activity of the PAG is 
increased by way of increased respiratory effort(Banzett et al. 2000; Von Leupoldt et al. 2009), it is 
hypothesized that the general function of the PAG is enhanced, including pain suppression. The effect of 
increased volitional breathing on systemic motor output has been recently studied (Li and Laskin 2006; Li 
and Yasuda 2007; Ikeda et al. 2009; Li and Rymer 2011a). Interestingly, along with reduction in muscle 
tone, reduction of central pain in chronic stroke patients has also been observed during voluntary- 
breathing controlled electrical stimulation (Li and Rymer 2011b; Li 2013) . This systemic effect of 
voluntary breathing on muscle tone and pain is possibly mediated via modulation of the PAG activity by 
voluntary breathing. We further infer that the enhanced PAG activity induced by voluntary breathing 
could lead to pain reduction. 
IRB NUMBER: HSC-MS-20-1032 

• 
Memory plays an important role in the awareness of persistent phantom limb pain Memory 
plays an important role in the awareness of persistent PLP as well as in the reinforcement of the 
associated distress, particularly important if chronic PLP is secondary to a traumatic event. Traumatic 
injury is usually a single event. The memory of the event could last for the rest of life. When associated 
with a negative emotional context, PLP after amputation could be perceived as aversive, and re-triggered 
by a stressful life event (Jensen et al. 1985). Functional connectivity studies demonstrate a prolonged, 
enhanced functional coupling in the resting state between amygadala, ACC, anterior insula and the 
sympathetic locus coeruleus after psychological stress (van Marle et al. 2010). Localized micro- 
stimulation to the insular cortex, when delivered during peripheral aversive stimulation, leads to item- 
specific impairment of aversive memory reconsolidation, i.e., anterograde amnesia (Stehberg et al. 
2009). In other words, peripheral aversive stimulation is not remembered. In our pilot study (Li et al. 
2012a; Li 2013), shooting phantom pain in a patient who had an above-the-knee amputation 
disappeared after treatment with breathing-controlled electrical stimulation (BreEStim) to the ipsilateral 
forearm, but re-appeared 28 days later after receiving a sustained electrical stimulation accidentally. This 
observation suggests that the affective component of noxious stimuli for shooting phantom limb pain has 
been modified by the BreEStim treatment, but then re-triggered by the accidental stimulation. This pilot 
observation supports the notion that the affective processing of neuropathic pain could be modified, 
possibly via BreEStim. 
 
New hypothesis on phantom limb pain after amputation 
A novel hypermnesia-hyperarousal model is proposed specifically to account for pain persistence and 
pain sensitization following a traumatizing event(Egloff et al. 2013). According to this model, a 
traumatizing event, such as limb amputation, usually results in activation of two self-protective 
mechanisms: hyper-sensitization (i.e., to detect a potential hazard as early as possible) and hypermnesia 
(i.e., not to forget the event in order to recognize it again and to avoid it). In case of severe traumatization 
like amputation, intense hypermnesia and hyperarousal are likely imprinted on the victim’s memories, 
and result in pain chronification and lower pain detection and tolerance thresholds (i.e., sensitization). 
We are aware that chronic PLP is multi-factorial. This model, however, offers a plausible explanation for 
chronic pain that is “unexplained” by structural damages after amputation. For example, when associated 
with a negative emotional context, phantom limb pain could be perceived as aversive, and re-triggered 
by a stressful life event(Jensen et al. 1985). Furthermore, the 
concept of trauma-induced pain sensitization and chronification 
has also provided a theoretical framework for a potential novel 
intervention, such as the one proposed in this application. 
 
 
Figure 1 Electrical sensation threshold (EST) (panel A) and 
electrical pain threshold (EPT) (panel B) in the PLP and non- 
PLP group. Mean and standard errors are shown. 
 
 
In our recent study (Li et al. 2015), we examined 
sensory thresholds in patients after traumatic amputation. We 
found hypersensitization in amputees with chronic phantom 
limb pain, but not in amputees without phantom limb pain 
(Figure 1). Thus, the findings support the concept of pain 
sensitization and chronification as a plausible underlying 
mechanism for neuropathic phantom limb pain. Specifically, it 
was the first time that tactile, thermal and electrical thresholds 
were comprehensively compared between the residual limb and 
the contralateral sound limb in patients with and without 
phantom limb pain. As shown in Fig 1, electrical pain threshold 
(EPT) was only decreased in the sound limb in the phantom 
limb pain (PLP) group and no difference among other three 
IRB NUMBER: HSC-MS-20-1032 
IRB APPROVAL DATE: 12/03/2020 
6 

IRB APPROVAL DATE: 12/03/2020 
7 
 
limbs (Fig 1B), suggesting central sensitization in patients with PLP. In contrast, electrical sensation 
threshold (EST) was increased on the affected limb as compared to the sound limb within the PLP group, 
but there were no significant differences in EST between the PLP and non-PLP group. There was 
essentially no significant difference in other thresholds (thermal and tactile). 
• 
Non-pharmaceutical modalities (acupuncture, TENS, aversive electrical stimulation) for 
PLP management 
Electrical stimulation (TENS) for painVarious neurostimulation techniques, including 
transcutaneous electrical nerve stimulation (TENS) (Norrbrink Budh and Lundeberg 2004), spinal cord 
stimulation (Finnerup et al. 2001b), deep brain stimulation (Murphy and Reid 2001), and transcranial 
direct current stimulation (Fregni et al. 2006) have been used for management of neuropathic pain. We 
are particularly interested in non-invasive stimulation that is relevant to our study – TENS. 
TENS is noninvasive, inexpensive, safe and easy to use. TENS for pain relief was fully accepted 
by the medical field after the publication by Wall and Sweet in 1967 (Wall and Sweet 1967) which 
provided experimental evidence supporting the gate theory of pain (Melzack and Wall 1965). TENS is 
usually applied at varying frequencies, intensities and pulse duration of stimulation for a prescribed 
treatment time. Frequency of stimulation is broadly classified as high frequency (>50Hz) or low frequency 
(<10Hz) or bursts of high frequency stimulation at a much lower frequency. Intensity is determined by 
patient’s response as either at the sensory level or motor level TENS. With the sensory level TENS, the 
stimulation intensity (voltage, or amplitude) is increased until the patient feels a comfortable 
tingling/tapping sensation without muscle contraction (twitching). With the motor level TENS, the intensity 
is increased to produce a motor contraction, but electrical stimulation is not noxious or painful. The usual 
TENS settings are high-frequency and low-intensity, or low-frequency and high-intensity. TENS has been 
applied to a variety of pain conditions, including phantom limb pain. Overall, the clinical effectiveness of 
TENS is controversial (see Review(Sluka and Walsh 2003; Mulvey et al. 2010; Johnson and Bjordal 
2011)). 
Several mechanisms are used to support the use of TENS for pain relief. The most common one 
is the gate control theory (Melzack and Wall 1965). Briefly, according to the gate control theory, small 
diameter fibers excite cells in the spinal cord that sends information to a higher center for the perception 
of pain. Large diameter fiber input reduces noxious input of nociceptor by activation of inhibitory neurons 
in the substantia gelatinosa of the spinal cord. Accordingly, stimulation of large diameter fibers by TENS 
inhibits nociceptive fiber evoked responses in the dorsal horn (Melzack and Wall 1965). Another theory is 
that TENS increases the release of endogenous opioids, subsequently blocking opioid receptors in the 
PAG-RVM pathway (Sluka et al. 1999; Kalra et al. 2001). Reports of clinical effectiveness of TENS for 
phantom limb pain even when applied to the contralateral side (Katz et al. 1989; Giuffrida et al. 2010) 
support the second theory – the release of endogenous opioids by TENS. 
Aversive stimulation and habituation When the intensity of stimulation increases to the extent that 
subjects feel pain, the stimulation becomes aversive or noxious. Ironically, repetitive painful stimulation 
leads to reduced pain, i.e., habituation (Bingel et al. 2007; Rennefeld et al. 2010). In a recent study 
(Rennefeld et al. 2010), daily painful thermal stimulation of the left volar forearm for l week was delivered 
to healthy subjects. Significant pain attenuation was observed at the site of stimulation, the contralateral 
arm and the ipsilateral leg. In the same study, the authors also found that pain habituation to noxious 
stimulation was unaffected by the opioid antagonist naloxone. Thus, these results strongly support a 
central mechanism of pain habituation that does not directly involve the endogenous opioid system. The 
naloxone non-reversible effect by aversive electrical stimulation suggested that the effect was mediated 
by a mechanism different from the release of endogenous opioids, as described for TENS and 
acupuncture. Brain imaging studies after painful thermal (Bingel et al. 2007) and electrical (Christmann et 
al. 2007) stimulation revealed that, in addition to decreased activity in classical pain areas, including 
thalamus, insula, putama and somatosensory cortices, pain-related responses in the ACC significantly 
decreased over time. The ACC has been reported to selectively process the aversive quality of noxious 
stimulation (LaGraize et al. 2006), but does not influence sensation of the stimulation (LaBuda and Fuchs 
2005). The brain imaging findings of decreased pain-related responses in the ACC after repetitive 
aversive stimulation indicates a negative effect on the affective processing of the stimulation, 
subsequently resulting in less unpleasantness over time, without changes in sensation of noxious stimuli. 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
8 
 
rated exten
Acupuncture and electro-Acupuncture for pain 
Acupuncture is a special kind of 
neurostimulation that is applied to acupuncture points (Acupoints). Acupoints are special points located 
in the periphery but are connected to internal organs including spinal cord and brain, following different 
channels, according to traditional Chinese medicine. Systematic investigation on mechanisms of 
acupuncture started in 1950s in China (Han 2004). Evidence on clinical effectiveness and mechanisms 
has accumulated over decades in Western Medicine literature (Hui et al. 2000; Han 2004; Yoo et al. 
2004; Cho et al. 2006; Dhond et al. 2008). Acupuncture for pain relief via the release of endogenous 
opioids has been well accepted in Western Medicine. Modification to traditional acupuncture needle has 
been made (Han et al. 1981; Han 2004). It has been replaced by a surface electrode (or equivalent). 
When a specialized electrode is placed over traditional acupoints, electrical stimulation is delivered. This 
modification has been termed electroacupuncture. Needle acupuncture and electroacupuncture are both 
effective in analgesia (Wan et al. 2001; Huang et al. 2002). The effect of electroacupuncture is usually 
reliable, but dependent on intensity and frequency of delivered electrical stimulation: different frequency 
of electrical stimulation generates different endogenous opioids, and the analgesic effect is naloxone- 
reversible (Huang et al. 2002; Han 2004). 
Aversive electrical stimulation to acupuncture points 
Theoretically, analgesic effects are 
anticipated to be strengthened if different mechanisms of treatment are delivered at the same time. 
Following this line, repetitive aversive electrical stimulation delivered to acupoints is expected to have 
combined effects: 1) habituation to aversive stimulation as described above; 2) analgesic effect 
secondary to the release of endogenous opioids secondary to stimulation of acupuncture points. 
Therefore, in combining different mechanisms (the release of endogenous opioids, habituation), aversive 
electrical stimulation to acupoints is theoretically anticipated to produce significant analgesic effects. 
Psychological/Cognitive coping /Cognitive behavioral therapy 
In addition to the above 
modalities, a variety of approaches is available for managing psychological and environmental 
contributions to pain and distress. Pharmacological strategies such as anxiolytic and antidepressant 
therapy and non-pharmacological strategies such as cognitive behavioral approaches may be used. The 
use of cognitive-behavioral therapy, including mirror therapy(Barbin et al. 2016) and virtual reality 
therapy(Ortiz-Catalan et al. 2016) has been reported to modify phantom limb pain. These techniques 
may act by modifying the central process involved in pain perception. 
• 
Human breathing and possible effects on modulation of pain 
As briefly mentioned, respiration and pain are co-modulated at the sub-cortical level (The PAG) as part of 
vital surviving functions. Human breathing is a very unique motor act. It can be controlled reflexively 
(automatic breathing), e.g., during sleep, while humans are also able to breathe voluntarily when needed 
(voluntary breathing), e.g., singing, speech, etc. Automatic breathing is believed to originate in the 
brainstem via the ponto-medullary respiratory oscillator. A descending bulbo-spinal projection from the 
oscillator synapses with the spinal cord anterior horn cells with rhythmic projections to the respiratory 
muscles to cause automatic breathing. The oscillator can function automatically without any peripheral 
feedback, and only responds to changes in pH and PCO2. (cf. review (Guz 1997)). In contrast, cortical 
inputs are required during voluntary breathing. Spinal motoneurons receive cortico-spinal inputs 
originating from discrete regions of the motor cortex where the respiratory muscles are represented. 
These cortical areas are clearly identified in humans (Gandevia and Rothwell 1987; Colebatch et al. 
1991; Maskill et al. 1991; Sharshar et al. 2004). Clinical evidence strongly suggests that bulbo-spinal 
fibers project separately from the relevant corticospinal fibers. For instance, patients with brainstem 
lesions (Plum and Leight 1981) or very high cervical cord lesions (Davis and Plum 1972; Lahuerta et al. 
1992) can breathe voluntarily, but lack automatic breathing when drowsy or asleep. Cortico-spinal 
pathways could bypass the brainstem respiratory centers and provide direct cortical control to the spinal 
respiratory motoneurons during voluntary breathing (Corfield et al. 1998). During normal functioning, 
spinal motoneurons are able to integrate these different sources, including descending cortico- and 
bulbo-spinal inputs and peripheral afferent inputs into a segmental interneuronal network (Aminoff and 
Sears 1971). 
During voluntary breathing, humans need to voluntarily suppress autonomic control of breathing 
(Guz 1997; Haouzi et al. 2006) through voluntary cortical activation (the “cortical respiratory center”). 
Brain imaging studies (Colebatch et al. 1991; Maskill et al. 1991; Ramsay et al. 1993; Fink et al. 1995; 
Evans et al. 1999; Smejkal et al. 1999; Smejkal et al. 2000; Macey et al. 2003; Macey et al. 2004; 
Mazzone et al. 2007; Evans et al. 2009; Evans 2010) have demonst 
sIiRveB iNnUvoMlvBeEmRe: HntSoCf-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
9 
 
cortical areas bilaterally, including the primary motor cortex (M1), the premotor cortex, the supplementary 
motor area, the primary and secondary somatosensory cortices, the insula, the ACC and amygdala, and 
the dorsolateral prefrontal cortex. The insula is known to have strong connections to brainstem centers 
(Tsumori et al. 2006). Respiratory specific insular connections include the medullary respiratory 
chemoreceptors and pulmonary stretch receptors (Gaytan and Pasaro 1998; Hanamori et al. 1998). 
Activity of the insular cortex is not modulated during automatic breathing, according to breath-by-breath 
analysis in a recent fMRI study (Evans et al. 2009). The insula and associated operculum, however, are 
consistently activated during various sensorimotor respiratory tasks (Evans 2010). Change in respiratory 
status, e.g., urge-to-cough (Mazzone et al. 2007), needs a change in pulmonary stretch receptor or 
chemoreceptors (Gaytan and Pasaro 1998; Hanamori et al. 1998), leading to increased activity in the 
insula, thus possibly to provide respiratory interoception (Craig 2002). 
• 
Breathing-controlled electrical stimulation (BreEStim) for pain management – Preliminary 
data 
During autonomic breathing, inspiration is active while expiration is passive, mainly relying on the 
recoil force of the chest wall. Similarly, volitional inspiration activates more respiratory-related cortical 
and subcortical areas as compared to volitional expiration (Evans et al. 1999). We have discovered that 
there exist interactions between respiratory and motor systems during voluntary breathing. Specifically, 
there is a finger extension-inspiration coupling (Li and Laskin 2006; Li and Yasuda 2007; Ikeda et al. 
2009; Li and Rymer 2011a). When electrical stimulation is delivered to the finger extensors during the 
inspiratory phase of voluntary breathing, a long-lasting effect of reduction in finger flexor spasticity 
(muscle tone) in chronic stroke patient is observed (Li and Rymer 2011a). We also observed interactions 
between voluntary breathing and pain modulation. In our pilot studies (Li et al. 2012a; Li 2013), shooting 
phantom pain in a patient who had an above-the-knee amputation disappeared after treatment with 
breathing-controlled electrical stimulation (BreEStim) to the ipsilateral forearm, but re-appeared 28 days 
later after receiving sustained electrical stimulation accidentally. This pilot case study provides a unique 
opportunity that the affective component of noxious stimuli for shooting phantom limb pain has been 
modified by the BreEStim treatment, but then re-triggered by the accidental stimulation. These 
observations of tone and pain reduction have led to a hypothesis that voluntary breathing, inspiration in 
particular, could be integrated into an electrical stimulation paradigm to improve its efficacy in 
neuropathic pain management. Though extensively used, efficacy of TENS in pain relief remains 
controversial (Sluka and Walsh 2003; Mulvey et al. 2010; Johnson and Bjordal 2011). Similar results of 
pain reduction after BreEStim treatment were also observed in a traumatic spinal cord injury patient with 
neuropathic pain (Li 2013). 
In these two cases, BreEStim to acupoints on the forearm was not likely to modify the sources of 
noxious stimuli at the level of spinal cord injury (thoracic area) or at the residual limb (i.e., lower 
extremity). Rather, BreEStim modified how patients react to the noxious stimuli at the central level, i.e., 
the affective response to the same stimuli. Our 
case reports suggest that patients could tolerate 
the same noxious stimuli better after BreEStim. 
This is possibly realized by increasing pain 
threshold as a final result from the intervention, 
i.e., de-sensitization, or less sensitive to painful 
stimuli. 
 
Figure 2 
Change of electrical pain 
threshold as percentage of pre-intervention 
values after BreEStim and EStim in healthy 
subjects. Standard errors are presented (From 
Li et al. 2013(Li et al. 2013)) 
NOTE: The intensity of electrical 
stimulation was comparable between BreEStim 
and EStim, suggesting that the effect is not 
mainly mediated by electrical stimulation itself. 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
10 
 
ulation is n
To test the hypothesis that BreEStim modifies pain threshold, subsequently resulting in reduction 
of neuropathic pain, we recently compared pain thresholds before and after BreEStim and EStim (Li et al. 
2013). Two interventions were tested in the same healthy subjects in a randomized order, but at least 3 
days apart in order to exclude any possible carry-over effect from the previous intervention. The results 
showed that BreEStim significantly increased 
electrical pain threshold, while EStim 
significantly decreased electrical threshold. 
Other thresholds (thermal, electrical sensation, 
and tactile sensation) remained the same after 
both interventions. Collectively, these findings 
suggest that BreEStim has selectively modified 
electrical pain threshold, i.e., affective 
component. 
 
 
Figure 3. Changes of electrical pain threshold 
as percentage of pre-intervention values after 
BreEStim and Breathing-only. Standard errors 
are shown. 
 
 
To further examine whether BreEStim-induced analgesic effect is primarily caused by voluntary 
breathing, we compared the effect of BreEStim and Breathing-only on experimentally induced pain in 
healthy subjects in another study in 2015(Hu et al. 2015). The same protocol was used. Electrical pain 
threshold increased to a similar extent as previously reported after BreEStim, but there was almost no 
change after Breathing-only (Figure 3). 
• 
BreEStim integrates multiple pain coping mechanisms 
Collectively, these findings suggest that BreEStim-induced analgesia is likely caused by internal 
pain-coping mechanisms activated during BreEStim, rather than by EStim or Voluntary Breathing alone. 
It is not the purpose of this project to investigate coping mechanisms of BreEStim. Rather, according to 
the above literature review, we speculate that could integrate various non-pharmacological coping 
mechanisms into one regime for PLP management. Here are possible mechanisms for BreEStim- 
induced analgesia and its de-sensitization effects. 
Acupuncture effect Acupuncture-related analgesic effects, via the release of endogenous opioids, 
are triggered when acupoints are stimulated (Hui et al. 2000; Wu et al. 2002). We want to point out that it 
is not the purpose of the project to distinguish whether analgesic effects are related to 
electroacupuncture or just electrical stimulation, since both are possibly mediated by the release of 
endogenous opioids when electrical stimulation is delivered transcutaneously. The main purpose of the 
project is to investigate whether BreEStim could be translated into management of neuropathic phantom 
pain in the target patient population. 
Habituation to aversive stimuli Pain-related responses decrease when painful stimulation is 
applied repetitively. It is important to mention that habituation to aversive stimuli is not naloxone- 
reversible, in other words, not mediated by the release of endogenous opioids (Rennefeld et al. 2010). 
Therefore, the above two mechanisms could have additive analgesic effects. 
Influence of voluntary breathing. Effortful inspiration and expiration requires extensive cortical and 
subcortical activation, as mentioned above. The activation is more extensive during voluntary inspiration 
than voluntary expiration. The insular cortex is consistently activated during various sensorimotor 
respiratory tasks. Meanwhile, the insular cortex is critical in affective processing of pain. As such, 
unpleasantness of pain may be modulated during voluntary-breathing associated activation of the insular 
cortex. Furthermore, voluntary-breathing associated activation in the PAG may also enhance the ability 
of the PAG-RVM pathway in modulation of pain. 
Anterograde amnesia to aversive stimulation When aversive stimulation is delivered during 
activation of the insular cortex, item-specific anterograde amnesia to the stimulation occurs (Stehberg et 
al. 2009). In other words, unpleasantness of peripheral noxious stim 
otIRreBmNeUmMbBeErRed: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
11 
 
immediately after the stimulation, when the insular cortex is activated during stimulation. Expectedly, 
unpleasantness of peripheral painful stimulation, when triggered by voluntary inspiration (the insular 
cortex is activated), is decreased or not remembered. As such, it is expected to facilitate habituation to 
aversive stimulation even at higher intensity, subsequently increasing the analgesic effect of stimulation. 
A positive feedback loop could occur that patients request a higher intensity of electrical stimulation, 
even noxious, for a better analgesic effect. 
The reward system is triggered As described above, this positive feedback loop is likely to occur 
by triggering the reward system, which is commonly associated with outcomes of aversive stimuli 
(Jensen et al. 2003). Expectedly, the intensity of aversive electrical stimulation is gradually driven higher 
during the course of stimulation. 
B. 
Research Hypotheses and Specific Aims 
The Main Research Hypothesis: In summary, BreEStim has advantages of integrating multiple internal 
pain-coping mechanisms to produce analgesia. We compared electrical pain threshold before and after 
BreEStim and EStim or Breathing-only in healthy subjects (Li et al. 2013; Li et al. 2014; Hu et al. 2015). 
Pain threshold was increased (i.e., de-sensitized) in both tested and contralateral hands after BreEStim, 
but decreased after EStim or Breathing-only without affecting other thresholds (thermal, electrical 
sensation, and tactile sensation). In other words, BreEStim has systemic de-sensitization effects. 
According to the literature, “unexplained” chronic pain after amputation, i.e., PLP, is a consequence of 
subsequent activation of "self-protection mechanisms" after amputationi, such as hyperamnesia and 
hyper-sensitization. Results from our preliminary study (Li et al. 2015) confirmed systemic sensitization in 
people with PLP. Therefore, we proposed the main hypothesized that BreEStim could provide non- 
pharmacological analgesic effects for patients with chronic phantom limb pain after limb 
amputation via central desensitization. Accordingly, we have the following specific aims. 
Specific Aim 1: To examine whether BreEStim could have better analgesic effects on PLP 
It is hypothesized that BreEStim has better analgesic effect than EStim, and the analgesic effect is 
accompanied by elevated electrical pain thresholds. Patients with PLP will receive both BreEStim and 
EStim in a randomized order with at least 3 days apart. The same amount of stimulation (120 electrical 
stimuli) at comparable intensities will be used as in our recent studies. According to our preliminary data, 
we expect that BreEStim has greater pain reduction and longer lasting effect. These results will parallel 
with increased electrical pain thresholds after BreStim, i.e., desensitization, as compared with EStim. 
Specific Aim 2: To examine whether BreEStim-induced analgesic effect is dose-dependent 
 
Similar to taking pain medications, it is hypothesized that there is a dose-response analgesic effect of 
BreEStim, i.e., an increased “dose” of BreEStim will have a greater impact on reduction of phantom limb 
pain. Two doses of BreEStim intervention (120 vs. 240 electrical stimuli) will be given to the same 
amputee with one week apart in a randomized order. According to our preliminary data from 3 subjects, 
we expect that that a high-dose BreEStim will produce a longer-lasting, but similar degree of pain 
reduction as compared to a low-dose BreEStim. The findings also suggest a possible cumulative effect of 
BreEStim, thus leading to a long term effect. 
Specific Aim 3: to examine the long-term effect of BreEStim on neuropathic PLP 
It is critical to know whether patients will tolerate electrical stimulation and the induced analgesic 
effect will diminish or the effect will accumulate if patients receive BreEStim repetitively over time, before 
it is translated into a therapeutic device. It is hypothesized that the BreEStim treatment will produce a 
greater analgesic effect than the convention electrical stimulation (EStim) treatment in patients after 
traumatic amputation over a course of 2 weeks (10 consecutive workdays). We will examine the 
hypothesis by comparing electrical pain threshold and effectiveness in pain reduction between BreEStim 
and EStim in patients after traumatic amputation of one limb. The analgesic effect will be assessed by 
pain reduction in visual analog scale and quantitative measurement of electrical sensation and pain 
thresholds. The effect on general well-being and change in pain medication will be assessed. 
 
 
 
 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
12 
 
4. Research design and methods: 
 
Location: Neurorehabilitation Research Laboratory at TIRR Memorial Hermann Hospital 
 
C. Each sample population is appropriate and of sufficient size 
 
Pilot data and sample size for Experiment 1 (Aim 1) 
In Experiment 1, we plan to use our recent BreEStim and EStim protocols(Li et al. 2013; Li et al. 2014) to 
compare the induced analgesic effects in patients after traumatic limb amputation. The same 
experimental protocol for quantitative sensory testing (QST) will be adopted. QST, including mechanical 
sensation threshold, thermal thresholds (cold/warm sensation, cold/hot pain) and electrical sensation and 
pain thresholds will be measured in four limbs. In the pilot study we only measured electrical sensation 
and pain threshold in these areas to estimate the sample size. 
We have tested the protocol in 3 patients with PLP after below-the-knee amputation (BKA) 
(Figure 4). On average, VAS scores decreased from 5.3 to 3.2 after BreEStim. The analgesic effect 
lasted 16.2 hours. In contrast, VAS scores changed from 4.9 to 4.1 after EStim. The effect lasted 2.0 
hours. Electrical sensation detection threshold (EDT) remained similar for both BreEStim (4.9 vs 5.0 mA, 
pre vs. post) and EStim (4.9 vs. 4.8 mA, pre vs. post). However, electrical pain threshold (EPT) 
increased from 22.8 to 29.3 mA after BreEStim – a change of 22.1%, in contrast, EPT was very similar 
before and after EStim (23.4 vs. 23.6 mA, pre vs. post). No difference in tactile and thermal thresholds 
was found. 
 
 
Figure 4 BreEStim produced a better and longer lasting analgesic effect than EStim in patients with 
phantom limb pain. 
Power analysis and estimate of sample size for Experiment 1 Ms. Yang (our biostatistician 
consultant) has performed power analysis based on our pilot study and historical data from the literature. 
A two-way repeated measures ANOVA was used to determine whether any change in VAS score was 
due to the interaction between INTERVENTION and TIME (i.e. whether one of two interventions is more 
effective at reducing VAS scores). A power analysis using the G*power computer program (Faul et al. 
2007) indicated that a sample of 12 people would be needed to detect a large effect size (> 0.8) with 
85% power using a repeated measures two-way ANOVA with alpha at .05, a sample of 14 people would 
be needed for 90% power. To account for possible subject withdrawal (10%), we plan to recruit 16 
subjects. Also to reduce the experimental bias and the order effect, the order of the interventions will be 
randomized. 
 
Pilot data and sample size for Experiment 2 (Aim 2) 
In Experiment 2, the same BreEStim protocol will be used, but at two different doses (120 stimuli 
vs. 240 stimuli). We have tested the protocol in 4 patients with phantom limb pain after BKA (Figure 5). 
On average, BreEStim120 and BreEStim240 had similar analgesic effects. VAS decreased from 6.4 to 
3.5 after BreEStim120, and from 5.9 to 3.5 after BreEStim300. However, the analgesic effect lasted 
longer after BreEStim240 (26.1 hours) than after BreEStim120 (14.5 hours). SimIiRlaBr tNoUEMxBpE2R,:tHheSCse-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
13 
 
analgesic effects were paralleled with similar degrees of change in EPT without changes in other 
thresholds. 
 
Figure 5 BreEStim has a dose-response effect on the duration, not the degree of analgesic effects on 
phantom limb pain. 
Power analysis and estimate of sample size for Experiment 2: Ms. Yang (our biostatistician 
consultant) has performed power analysis based on our pilot data. One-group paired t-test was used to 
examine whether patients had longer duration of analgesic effects after BreEstim240 than BreEstim120. 
A power analysis using the G*power computer program (Faul et al. 2007) indicated that a sample of 13 
people would be needed to detect large effects (d=0.8) with 85% power using a one-tailed paired t-test 
between two dependent means with alpha at .05, a sample of 16 people would be needed for 90% 
power (An effect size of 0.8 is estimate based on the large effect size observed in pilot studies). We plan 
to recruit 18 subjects in case some subjects could not come for the second session. 
Pilot data and sample size for Experiment 3 (Aim 3) 
We have tested two amputee subjects with chronic neuropathic PLP greater than 4 years. Subjects were 
young and medically stable. Both interventions were delivered in the same time of the day, and patients 
took the same medications during the course of treatment. BreEStim and EStim were delivered with 2 
weeks apart for washout effects. The order of treatment was balanced between two subjects. 
Medications were or had been stable for at least 2 weeks prior to the first test. To demonstrate detailed 
responses after each treatment and the intensity of each treatment session, Figure 6 shows findings from 
one subject. 
 
Figure 6 BreEStim and EStim in an 
amputee subject. The amputee 
subject (male, 31 years of age, Left 
above-the-knee amputation 5 years 
ago) received BreEStim first, waited 
for 1 week for washout, then 
received electrical stimulation only 
(EStim, without voluntary breathing). 
Surface electrodes were placed on 
the skin overlying the median nerve 
about 3 centimeters above the wrist 
joint for both BreEStim and EStim. A 
single electrical stimulus was 
triggered by voluntary breathing 
(BreEStim) or triggered randomly by 
a computer (EStim). The duration of 
single stimulus was 0.1 ms. The 
intensity of electrical stimulation (the 
lower panels, in pink) was 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
14 
 
comparable among interventions (Figure 6). Overall, BreEStim had greater analgesic effect than EStim 
(the upper panels, in blue). Patient tolerated both interventions well. No side effect was reported. 
Power analysis and estimate of sample size for Experiment 3 
Ms. Yang (our biostatistician 
consultant) has performed power analysis based on our pilot study and historical data from the literature. 
Using nQuery Advisor® , we applied the t-test (ANOVA) for difference of VAS in 2 x 2 crossover design 
with a 0.05 two-sided significance level. To achieve 80% power of detecting a difference in VAS of 3.0 
(the difference between the mean of group BreEStim, µ1=4.0 and the mean of EStim group, µ2=2.0) 
assuming that the Crossover ANOVA √MSE is 3.4 (the Standard deviation of differences, σd, is 4.8), the 
sample size is 24. Assuming an expected dropout rate of 20% given the long-term intervention, we 
proposed to recruit 30 patients in total for Experiment 3. 
D. The data collection and measurement techniques are appropriate and effective 
• 
Experimental Design 
The overall research design is a within-group, randomized controlled study to compare analgesic 
effects between EStim and BreEStim (single-session in Exp 1, long-term intervention in Exp 3), between 
BreEStim120 and BreEStim240 (Exp2). We prefer this within-group comparison because 1) pain, by 
nature, is a subjective perception, it is difficult to control (physical, social, psychological) multi-factors 
between two groups; 2) It will be fair that all subjects receive the innovative intervention, which is 
superior to regular electrical stimulation according to our pilot data; 3) according to our recent BreEStim 
study in patients with spinal cord injury, the duration of analgesic effect was 15 hours after one-session 
of BreEStim treatment. An interval of one week for washout should be sufficient for Exp 1 & 2. The 
washout interval will be 2 weeks for Exp 3. It is our experience with subjects with spinal cord injury that 
an interval of 7 days is sufficient for subjects to return to their baseline after BreEStim treatment. (Li et al. 
2016; Karri et al. 2018b; Li et al. 2018) However, we did notice that one subject with post-amputation 
PLP had carry-over effect for one month(Li et al. 2012a). We plan to screen these patients with long- 
lasting carry-over effects. These patients will be excluded from the subject should this happen. 
In Experiment 1, we plan to use our recent BreEStim and EStim protocols (Li et al. 2013; Li et al. 
2014; Li et al. 2016) to measure mechanical sensation threshold, thermal (cold/warm detection, cold/hot 
pain) thresholds, and electrical sensation and pain thresholds in the treatment limb and contralateral 
limb. The same group of subjects will receive both BreEStim and EStim at a randomized yet balanced 
order with at least 7 days apart. The same amount of electrical stimulation (120 stimuli) will be given 
during both BreEStim and EStim. The purpose of this aim is to investigate whether BreEStim could have 
better analgesic effect than EStim in amputee subjects with chronic phantom limb pain as we observed in 
healthy subjects. We expect increased electrical pain thresholds in both limbs after BreEStim because of 
its central desensitization effects. 
In Experiment 2, a group of subjects will receive BreEStim at two different doses (120 vs. 240 
stimuli) on two different days with at least 7 days apart. The purpose is to compare the extent and 
duration of analgesic effects between two doses of BreEStim. We expect that BreEStim240 could have 
similar degree of pain reduction but with longer duration compared to BreEStim120, as shown in our pilot 
study. Therefore, we expect to use BreEStim240 in Experiment 3 for the long-term intervention. 
 
 
Figure 7: Illustration of study design for Experiments 3 
IRB NUMBER: HSC-MS-20-1032 

IRB NUMBER: HSC-MS-20-1032 
IRB APPROVAL DATE: 12/03/2020 
15 
 
In Experiment 3, the same established protocol will be used (Li et al. 2012a; Li 2013). The effect 
of two interventions (BreEStim and EStim) will be compared. Each intervention consists of 240 
stimuli/session (about 40-50 min/session), 1 session/day for 10 consecutive sessions (over 2 weeks). 
After a follow-up (wash-out) period of two weeks, the same subject will be treated with the other 
intervention with a same follow up of 2 weeks. The intensity of stimulation will be adjusted as subjects 
could tolerate. Electrical stimulation will be delivered to the median nerve on the dominant side. The 
wash-out/follow-up period of 2 weeks allows removal of accumulative or carry-over effect from the 
previous intervention. 
It is expected that electrical pain threshold will be further increased after BreEStim with parallel 
reduction in pain perception, while there is no or minimum change after EStim and no significant change 
in pain perception. Pain threshold will be measured using QST. Pain perception will be characterized by 
duration and amount of change in pain on visual analog scale (VAS), i.e., how much pain is reduced and 
how long it lasts. As such the effect of treatment is quantified by reduction x hours. 
The secondary outcome measurement will be General Well-Being (GWB) Schedule Survey and 
Center for Epidemiologic Studies Depression Scale (CES-D), NIMH Survey to examine the possible 
effect of pain reduction on general well-being, depression and quality of life of the patients. These 
surveys have been well validated and commonly used (Sherman et al. 1984; Wartan et al. 1997; 
Kooijman et al. 2000). 
The long-term BreEStim treatment is expected to have some cumulative analgesic effects. 
However, we decide to keep the same regime of medications, because change in medications will be a 
confounding factor. Therefore, the subjects will be explicitly instructed to maintain the same dose and 
frequency of pain medications after the BreEStim treatment even if pain is improved. The collaborating 
investigator Dr. Melton will screen and monitor their medications. This is exploratory at this time. If the 
baseline pain level improves after the 2-week BreEStim treatment, a clinical trial is warranted. Change in 
pain medications may be explored further in the future studies. 
• 
Experimental setup (BreEStim and EStim protocols and measurement) 
Experiment 1 We plan to use our recent BreEStim and EStim protocols (Li et al. 2013; Li et al. 
2014). Briefly, subjects will be seated comfortably with the arm on the experimental table (Fig 8). 
Subjects will wear a facemask that will be connected to a Pneumotach system to record breathing 
signals and to prevent hyperventilation. Surface electrodes will be trimmed to be applied to the median 
nerve ipsilateral to the affected side proximal to the wrist line (see Fig 8). Note that important 
acupuncture points (Neiguang and Waiguan) are located beneath the electrodes. So these points will be 
stimulated during both BreEStim and EStim). 
 
 
Figure 8 Experimental settings. On the right panel, an electrical stimulus (Lower) is triggered when the 
airflow rate (Upper) of a forceful inhalation reaches 40% of its maximum value. 

IRB NUMBER: HSC-MS-20-1032 
IRB APPROVAL DATE: 12/03/2020 
16 
 
In the BreEStim treatment, a single-pulse electrical stimulus is delivered to the nerve when 
patients are taking fast, strong, and deep inhalation, similar to a deep breath but faster and stronger. 
Voluntary inhalation plays an important role in this intervention. Voluntary inhalation is defined as effortful 
deep and fast inhalation. Subjects are instructed to take a deep breath, similar to routine deep breaths, 
but faster and stronger, usually involving obvious expansion of chest wall. It has been reported that there 
are respiratory specific connections between the insula and the activity of pulmonary stretch receptors 
(Gaytan and Pasaro 1998; Hanamori et al. 1998). Experimentally, the airflow rate is monitored online. 
When the airflow rate reaches 40% of its peak, an electrical pulse is triggered (Li et al. 2012a; Li 2013). 
The frequency of BreEStim generally varies. As in our previous series of BreEStim experiments, subjects 
are usually comfortable to continue voluntary breathing for 20 – 30 electrical stimuli without a break. As 
seen in Figure 8, BreEStim is delivered at about every 2 seconds. The single-pulse electrical stimulus is 
a square wave with a width of 0.1 ms. The intensity is set where subjects feel painful but yet tolerable, 
equivalent to 7 on the 0-10 VAS scale. When wearing a face mask, subjects usually tolerate such 
breathing very well. No hyperventilation has been reported (Li et al. 2012a; Li 2013). 
In the EStim condition, subjects will also wear the face mask as in the BreEStim condition. The 
main difference is that subjects will be breathing automatically and comfortably and electrical stimulation 
pulses will be delivered randomly. The pulses will be programmed to randomly deliver at about every 2 
seconds (between 1.9 seconds and 2.1 seconds). The pulse width will be the same at 0.1ms. Similarly, 
subjects control the intensity of electrical stimulation. For both BreEStim and EStim, they are strongly 
encouraged to increase the intensity to be painful yet tolerable gradually from their pain threshold. The 
level of pain with painful stimulation will be 7 on the 0-10 VAS scale. The purpose is to make the intensity 
of electrical stimulation comparable between two conditions. According to previous studies, the intensity 
is comparable between BreEStim and EStim(Li et al. 2013; Li et al. 2014).The intensity of electrical 
stimulation will be recorded during the course of treatment. 
Two interventions (BreEStim vs. EStim) will be given to the same subject on a different day with 
at least 7 days apart. As in previous studies(Li et al. 2013; Li et al. 2014), a total of 120 electrical stimuli 
will be delivered for each intervention. The order of interventions will be randomized and balanced across 
subjects. Both interventions will be given at the same time of the day, as determined by subject’s 
schedule. It is important to emphasize that subjects will be explicitly instructed to maintain the same pain 
regime even they feel that treatment has helped in pain reduction, such that pain reduction is mainly 
related to BreEStim or EStim. 
Outcome measurement includes visual analogue scale (VAS) and Quantitative Sensory 
Testing (QST) and Hear rate variability (HRV). The VAS method has been extensively used and 
validated (McCarthy et al. 2005). Using VAS to rate pain intensity has been considered a standardized 
measurement to evaluate effectiveness of deep brain stimulation for pain management in a multi-center 
study by Medtronic (Medtronic, Minneapolis, MN). These results have been reported to US Food and 
Drug Administration for judgment on the efficacy of pain management(Coffey 2001). In the project, we 
plan to use a modified VAS to quantify pain reduction. As used in our pilot study (Li et al. 2012a; Li 
2013), the effect of pain reduction is characterized by duration and amount of change in pain on VAS, 
i.e., how much pain is reduced and how long it lasts. As such the effect of treatment is quantified by 
reduction×hours. The effect and the intensity of stimulation will be recorded daily during the course of 
treatment. For VAS, the duration of analgesic effect from the intervention will also be recorded. VAS 
scores will be obtained before and 10 minutes after. Post-intervention VAS will be also assessed through 
follow-up phone calls every 4 hours except night time (10pm – 7am). It is important to emphasize that 
subjects will be explicitly instructed to maintain the same pain medication regimen even if they feel that 
treatment have helped in pain reduction. 
QST includes tactile sensation threshold (TST), electrical sensation threshold (EST), electrical 
pain threshold (EPT), and thermal thresholds. VAS and QST will be recorded immediately before and 10 
minutes after the interventions. In this experiment, we aim to test the central de-sensitization effect of 
BreEStim. To standardize QST (Li et al. 2015), all thresholds will be measured only on the residual limb 
at 5 cm above the distal residual limb. The symmetrical site on the contralateral limb will also be 
localized. After the target areas are localized and marked with a marker, subjects are instructed to stay 
relaxed in a chair with arms and legs comfortably supported in a symmetrical position. The order of QST 
will be randomized and balanced across testing sites. The following measurement will be made. 

17 
 
Tactile sensation threshold: Tactile sensation threshold will be tested using Von Forey filaments 
(Touch-Test Sensory Evaluator, North Coast Medical Inc.). The center of the thenar eminence/testing 
sites on the leg will be marked with a pen symmetrically on both hands. Subjects will be instructed to 
close their eyes. The experimenter will press the filament at a 90° angle against the marked area until it 
bows for approximately 1.5 seconds and then removed. Testing will begin with the thinnest 1.65 filament, 
then progresses to the next monofilaments. An explicit response of touch sensation is defined as tactile 
sensation threshold. 
Electrical sensation and pain thresholds: The same trimmed electrodes will be used to examine 
electrical sensation threshold and electrical pain thresholds (electrical stimulator 7SA, Digitimer). A pair 
of electrodes is placed next to each testing site. For electrical sensation threshold, the intensity of 
electrical stimulation will start from zero and gradually increase in steps of 0.1 mA. Similarly, subjects will 
be instructed to close their eyes and to say “yes” when they explicitly feel electrical stimulation. Three 
repetitions will be made and the average will be used as the electrical sensation threshold. Electrical pain 
threshold is then measured. The intensity of electrical stimulation will start from the sensation threshold 
level and increase in steps of 1 mA. The electrical pain threshold is reached when subjects first feel 
electrical stimulation painful. To improve consistency among subjects, they are advised that the pain 
threshold level is equivalent to 1 on the 0-10 VAS scale. Similarly, the average of three tests will be used 
as the electrical pain threshold. 
Thermal thresholds: Thermal thresholds (warm sensation, cold sensation, heat pain, cold pain) 
will be examined using a Medoc PATHWAY system. The established “Limits Full Series” protocol will be 
selected. Briefly, the protocol contains a series of tests in the following order: 4 tests of cold sensation 
threshold, 4 tests of warm sensation threshold, 3 tests of cold pain threshold, and 3 tests of heat pain 
threshold. The 30x30 ATS probe is secured with its center on the testing. Subjects will have an education 
session prior to the protocol. The averaged value will be used for each threshold. 
Heart rate variability as objective outcome measurements: We have been searching for non- 
invasive objective pain outcome assessment. Heart rate variability has been recognized as a 
physiological marker for pain assessment (Appelhans and Luecken 2008; Karri et al. 2018b; Karri et al. 
2019). We will follow our recent experimental procedures (Karri et al. 2018b; Karri et al. 2019) to collect 
5 minutes of Heart Rate recordings before and after the interventions. 
Experiment 2 
The aim of this experiment is to explore this “dose-response” effect 
of BreEStim, by comparing the analgesic effects of two doses of single-session BreEStim. The same 
BreEStim protocol in Exp 1 will be used for Exp 2. In Exp 2, only BreEStim will be used. Two doses of 
BreEStim (120 vs. 240 electrical stimuli) will be given at least one week apart in a randomized order. 
Outcome measures, including VAS, QST thresholds, will be recorded pre- and 10 minutes post- 
intervention. Duration of analgesic effect (lasting hours) will also be recorded. 
Experiment 3 
The experimental set-up will be similar to Experiments 1&2. There are two 
different interventions – BreEStim and EStim. Each intervention consists of 240 stimuli/session (about 
40-50 min/session), 1 session/day for 10 sessions (over 2 weeks, no treatment in the weekends). After a 
follow-up (wash-out) period of two weeks, the same subject will be treated with the other intervention with 
a same follow-up of 2 weeks. The intensity of stimulation will be increased gradually as patients could 
tolerate. Aversiveness of electrical stimulation is part of treatment strategy. During EStim, a single-pulse 
electrical stimulation is delivered to the forearm through surface electrodes randomly, while electrical 
stimulation is triggered by volitionally effortful inhalation during BreEStim as in Exp 1. 
 
 
Specimens: 
No specimens will be collected 
 
 
5. Human Subjects 
 
As mentioned above, we plan to recruit a total of 64 amputee subjects with phantom limb pain, 
including 16 subjects for Aim 1, 18 subjects for Aim 2, and 30 subjects for Aim 3. The number of 
subjects was estimated based on the pilot data. 
 
• 
Subject recruitment/assignment 
IRB NUMBER: HSC-MS-20-1032 
IRB APPROVAL DATE: 12/03/2020 

IRB APPROVAL DATE: 12/03/2020 
18 
 
mation will
The collaborating physician (Co-I, Dr. Melton) will screen patients from the outpatient clinic of 
TIRR Memorial Hermann Hospital. We plan to register the project on www.clinicaltrials.gov. If 
patients are not currently seen by Dr. Melton, but are willing to participate in the project, they need to 
see Dr. Melton for screening and monitoring. In addition, Dr. Melton will monitor medical conditions of 
the patients and manage medical problems as needed. Patients will be recruited and enrolled in the 
project if they meet the following criteria: 
Inclusion criteria: A patient who 1) has neuropathic PLP after amputation of one limb, upper or 
lower limb; NOTE that BreEStim has been shown to be effective for neuropathic pain management in 
patients after traumatic and non-traumatic spinal cord injury in recent studies(Li et al. 2016; Li et al. 
2018). Therefore, we plan to recruit patients with chronic neuropathic PLP from both traumatic and 
non-traumatic limb amputation. 2) has chronic pain, >3 months; 3) is between 18 to 75 years of age; 
4) is stable on oral pain medications at least two weeks. Patients are instructed to continue their pain 
medications as prescribed during the intervention period. 
Exclusion criteria: Patients will be excluded if they 1) are currently adjusting oral pain 
medications for their neuropathic pain; 2) have pain, but not neuropathic, e.g., from inflammation at 
the incision wound of the residual limb; 3) have a pacemaker to avoid possible side effect of electrical 
stimulation; 4) have amputation in multiple limbs; 5) are not able to follow commands, or to give 
consent; 6) have asthma or other pulmonary disease; 7) are not medically stable. 
 
Gender will be balanced 
 
Potential subject populations and recruitment: Subjects will be recruited from TIRR outpatient clinic. 
 
6. Data Collection and Analysis 
 
Data collection details have been described above. Data analysis is described here. 
Experiment 1 
Repeated-measures two-way ANOVA tests with factors INTERVENTION (2 levels, 
BreEStim and EStim) and TIME (pre- and post-intervention) will be tested on dependent variables, 
including VAS, QST thresholds (tactile, electrical, and thermal), to determine statistical significance 
between two interventions. Paired t-tests will be used to compare the duration of lasting hours 
between two interventions. p value is set at 0.05. As observed in the pilot data, we expect that 
BreEStim could have central desensitization and analgesic effects on patients with phantom limb 
pain, but no such effect after EStim. These findings would suggest that the central desensitization 
effect of BreEStim could be translated to analgesic effects in patients with PLP. Furthermore, the 
findings of analgesic effects along with desensitization effects in patients with PLP support central 
sensitization as a plausible mechanism that mediates post-traumatic PLP. 
Experiment 2 
Similar to Exp 1, repeated-measures two-way ANOVA tests with factors 
INTERVENTION (2 levels, BreEStim 120 vs. 240) and TIME (pre- and post-intervention) will be 
tested on dependent variables, including VAS, QST thresholds (tactile, electrical, and thermal), to 
determine statistical significance between two interventions. Paired t-tests will be used to compare 
the duration of analgesic effect (lasting hours) between two interventions. p value is set at 0.05. As 
shown in the pilot data, we expect that BreEStim could have dose-dependent effects on the duration 
but not the degree of analgesic effects. These results also suggest that BreEStim could have 
cumulative effects if patients receive interventions repeatedly over a period of time. 
In Experiment 3, 
Repeated-measures two-way ANOVA will be performed to determine 
statistical significance between two interventions. Factors include INTERVENTION (BreEStim vs. 
EStim) and TREATMENT (Pre- and Post-intervention, and Followup). Variables are VAS and 
modified VAS and QST parameters, GWB, and CES-D. It is hypothesized that the effect of pain 
reduction is greater in BreEStim than in EStim for amputation patients, manifested by pain reduction 
on VAS assessment and parallel change of increased electrical pain threshold as shown by pilot 
data in Experiments 3. Furthermore, pain reduction is accompanied by improvement in general well- 
being and mood. 
 
Demographic data will be analyzed descriptively. Personal infor 
bIeRBdeN-UidMenBtEifRie:dH. SC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
19 
 
7. Potential Risks/Discomforts: 
 
The risks associated with this study are minimal. Electrical stimulation has been used 
extensively in clinical settings. Patients may feel uncomfortable, or even painful during 
electrical stimulation. The patients will be specifically instructed that they are encouraged 
to increase the intensity of electrical stimulation to the level they may feel comfortable, 
but they need to be able to tolerate at that level if given repetitively. They are also 
explicitly instructed to decrease the intensity of electrical stimulation if they can not 
tolerate it. Surface electrodes can cause skin irritation from the tape adhesive or the 
electrode paste. Breathing through a face mask may be make patients feel 
uncomfortable. All tested subjects in the previous studies (approximately 100 subjects, 
including patients) tolerated the mask well. 
 
8. Benefits: 
 
There are several potential benefits in this study: 1) direct benefit to subjects as their 
neuropathic pain may be relieved by the intervention; 2) benefit to the class of subjects: 
other patients in the same patient population may be benefit if the intervention is applied 
to them; 3) adding to the knowledge base: the findings will be definitely added to the 
knowledge base. Specifically, the study will provide evidence of an alternative and 
innovative intervention for neuropathic pain management after amputation. 
 
9. Risk-benefit Ratio: 
 
In view of the minimal risk, the knowledge to be gained far outweighs the risks. 
 
10. Consent Procedures: 
 
Informed consent will be obtained from the subject. After the subject is identified and is interested in 
participating, informed, written consent will be obtained by the investigator. 
 
11. Confidentiality Procedures: 
 
In order to minimize risk to confidentiality, all data will be de-identified, coded with a study-specific 
identification number, maintained on a password-protected server, and/or kept in a locked office. No 
findings will be released without written authorization by the subject or requests by law. 
 
12. Costs: 
 
The subject will not be expected to pay any costs. 
 
13. Payments: 
 
Subjects will receive a gift card of $40 for their participation in each session for Experiment 1 and 2. 
Experiment 3, each subject will have a total of 20 sessions (10 consecutive sessions of BreEStim, and 
10 consecutive sessions of EStim, with 2 weeks apart). Each subject will receive a giftcare of $40 
after the first session. Each of them will receive a total of $800 after the completion of all 20 sessions. 
No monetary compensation will be given if 20 sessions are not completed. This is to keep 
commitment and for subject retention. 
 
 
14. References: 
IRB NUMBER: HSC-MS-20-1032 

20 
 
Adams, P. F., Hendershot, G. E., Marano, M. A. (1999) Current estimates from the National Health 
Interview Survey, 1996. Vital Health Stat 10,1-203 
Alviar, M. J., Hale, T., Dungca, M. (2011) Pharmacologic interventions for treating phantom limb pain. 
Cochrane database of systematic reviews (Online) 12 
Aminoff, M. J., Sears, T. A. (1971) Spinal integration of segmental, cortical and breathing inputs to 
thoracic respiratory motoneurones. J Physiol 215,557-575 
Apkarian, A. V., Bushnell, M. C., Treede, R. D., Zubieta, J. K. (2005) Human brain mechanisms of pain 
perception and regulation in health and disease. Eur J Pain 9,463-484 
Appelhans, B. M., Luecken, L. J. (2008) Heart rate variability and pain: Associations of two interrelated 
homeostatic processes. Biological Psychology 77,174-182 
Banzett, R. B., Mulnier, H. E., Murphy, K., Rosen, S. D., Wise, R. J., Adams, L. (2000) Breathlessness in 
humans activates insular cortex. Neuroreport 11,2117-2120 
Barbin, J., Seetha, V., Casillas, J. M., Paysant, J., Pérennou, D. (2016) The effects of mirror therapy on 
pain and motor control of phantom limb in amputees: A systematic review. Annals of Physical and 
Rehabilitation Medicine 59,270-275 
Bennett, M. I. (2010) Neuropathic pain. Oxford University Press Inc., New York 
Bingel, U., Schoell, E., Herken, W., Büchel, C., May, A. (2007) Habituation to painful stimulation 
involves the antinociceptive system. Pain 131,21 
Boly, M., Faymonville, M. E., Schnakers, C., et al. (2008) Perception of pain in the minimally conscious 
state with PET activation: an observational study. Lancet Neurol 7,1013-1020 
Calejesan, A. A., Kim, S. J., Zhuo, M. (2000) Descending facilitatory modulation of a behavioral 
nociceptive response by stimulation in the adult rat anterior cingulate cortex. European Journal of 
Pain 4,83 
CARA (2016) http://nasadad.org/2016/07/comprehensive-addiction-and-recovery-act-of-2016-s-524-as- 
passed-by-house-and-senate-a-section-by-section-analysis/. 
Cho, Z. H., Hwang, S. C., Wong, E. K., et al. (2006) Neural substrates, experimental evidences and 
functional hypothesis of acupuncture mechanisms. Acta Neurologica Scandinavica 113,370 
Christmann, C., Koeppe, C., Braus, D. F., Ruf, M., Flor, H. (2007) A simultaneous EEG-fMRI study of 
painful electric stimulation. NeuroImage 34,1428 
Coffey, R. J. (2001) Deep brain stimulation for chronic pain: results of two multicenter trials and a 
structured review. Pain Med 2,183-192 
Colebatch, J. G., Adams, L., Murphy, K., et al. (1991) Regional cerebral blood flow during volitional 
breathing in man. J Physiol 443,91-103 
Corfield, D. R., Murphy, K., Guz, A. (1998) Does the motor cortical control of the diaphragm 'bypass' the 
brain stem respiratory centres in man? Respir Physiol 114,109-117 
Costigan, M., Scholz, J., Woolf, C. J. (2009) Neuropathic pain: A maladaptive response of the nervous 
system to damage. In: Annual Review of Neuroscience, vol 32, p 1 
Craig, A. D. (2002) How do you feel? Interoception: The sense of the physiological condition of the body. 
Nature Reviews Neuroscience 3,655 
Davis, J. N., Plum, F. (1972) Separation of descending spinal pathways to respiratory motoneurons. Exp 
Neurol 34,78-94 
De Ridder, D., Elgoyhen, A. B., Romo, R., Langguth, B. (2011) Phantom percepts: Tinnitus and pain as 
persisting aversive memory networks. Proceedings of the National Academy of Sciences of the 
United States of America 108,8075-8080 
Dhond, R. P., Yeh, C., Park, K., Kettner, N., Napadow, V. (2008) Acupuncture modulates resting state 
connectivity in default and sensorimotor brain networks. Pain 136,407 
Egloff, N., Hirschi, A., von Kanel, R. (2013) Traumatization and chronic pain: a further model of 
interaction. J Pain Res 6,765-770 
Ephraim, P. L., Wegener, S. T., MacKenzie, E. J., Dillingham, T. R., Pezzin, L. E. (2005) Phantom pain, 
residual limb pain, and back pain in amputees: Results of a national surveyIR. BANrcUhMivBeEs Ro:f HPShCy-sMicSa-l20-1032 
Medicine and Rehabilitation 86,1910-1919 
IRB APPROVAL DATE: 12/03/2020 

IRB NUMBER: HSC-MS-20-1032 
IRB APPROVAL DATE: 12/03/2020 
21 
 
Evans, K. C. (2010) Cortico-limbic circuitry and the airways: Insights from functional neuroimaging of 
respiratory afferents and efferents. Biological Psychology 84,13 
Evans, K. C., Dougherty, D. D., Schmid, A. M., et al. (2009) Modulation of spontaneous breathing via 
limbic/paralimbic-bulbar circuitry: An event-related fMRI study. NeuroImage 47,961 
Evans, K. C., Shea, S. A., Saykin, A. J. (1999) Functional MRI localisation of central nervous system 
regions associated with volitional inspiration in humans. J Physiol 520 Pt 2,383-392 
Faul, F., Erdfelder, E., Lang, A. G., Buchner, A. (2007) G*Power 3: a flexible statistical power analysis 
program for the social, behavioral, and biomedical sciences. Behav Res Methods 39,175-191 
Fields, H. L., Basbaum, A. L. (1999) Central nervous system mechanisms of pain modulation (Chap 12). 
In: Wall PD, Melzack R (eds) Textbook of pain, New York, pp 243-257 
Fink, G. R., Adams, L., Watson, J. D., et al. (1995) Hyperpnoea during and immediately after exercise in 
man: evidence of motor cortical involvement. J Physiol 489 ( Pt 3),663-675 
Finnerup, N. B., Johannesen, I. L., Sindrup, S. H., Bach, F. W., Jensen, T. S. (2001a) Pain and dysesthesia 
in patients with spinal cord injury: A postal survey. Spinal Cord 39,256-262 
Finnerup, N. B., Yezierski, R. P., Sang, C. N., Burchiel, K. J., Jensen, T. S. (2001b) Treatment of spinal 
cord injury pain. Pain Clin Updates 9,1-6 
Flor, H., Elbert, T., Knecht, S., et al. (1995) Phantom-limb pain as a perceptual correlate of cortical 
reorganization following arm amputation. Nature 375,482 
Fregni, F., Boggio, P. S., Lima, M. C., et al. (2006) A sham-controlled, phase II trial of transcranial direct 
current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain 122,197- 
209 
Freund, W., Wunderlich, A. P., Stuber, G., et al. (2011) The role of periaqueductal gray and cingulate 
cortex during suppression of pain in complex regional pain syndrome. Clin J Pain 27,796-804 
Frot, M., Mauguiere, F., Magnin, M., Garcia-Larrea, L. (2008) Parallel processing of nociceptive A-delta 
inputs in SII and midcingulate cortex in humans. J Neurosci 28,944-952 
Gandevia, S. C., Rothwell, J. C. (1987) Activation of the human diaphragm from the motor cortex. 
Journal of physiology 384,109-118 
Gauriau, C., Bernard, J. F. (2002) Pain pathways and parabrachial circuits in the rat. Experimental 
Physiology 87,251 
Gaytan, S. P., Pasaro, R. (1998) Connections of the rostral ventral respiratory neuronal cell group: an 
anterograde and retrograde tracing study in the rat. Brain Res Bull 47,625-642 
Giuffrida, O., Simpson, L., Halligan, P. W. (2010) Contralateral stimulation, using TENS, of phantom 
limb pain: two confirmatory cases. Pain Med 11,133-141 
Green, A. L., Wang, S., Purvis, S., et al. (2007) Identifying cardiorespiratory neurocircuitry involved in 
central command during exercise in humans. Journal of Physiology 578,605 
Guz, A. (1997) Brain, breathing and breathlessness. Respir Physiol 109,197-204 
Hadjipavlou, G., Dunckley, P., Behrens, T. E., Tracey, I. (2006) Determining anatomical connectivities 
between cortical and brainstem pain processing regions in humans: A diffusion tensor imaging 
study in healthy controls. Pain 123,169 
Hall, N., Eldabe, S. (2018) Phantom limb pain: a review of pharmacological management. British Journal 
of Pain 12,202-207 
Han, J. S. (2004) Acupuncture and endorphins. Neuroscience Letters 361,258 
Han, J. S., Li, S. J., Tang, J. (1981) Tolerance to electroacupuncture and its cross tolerance to morphine. 
Neuropharmacology 20,593-596 
Hanamori, T., Kunitake, T., Kato, K., Kannan, H. (1998) Neurons in the posterior insular cortex are 
responsive to gustatory stimulation of the pharyngolarynx, baroreceptor and chemoreceptor 
stimulation, and tail pinch in rats. Brain Res 785,97-106 
Haouzi, P., Chenuel, B., Barroche, G. (2006) Interactions between volitional and automatic breathing 
during respiratory apraxia. Respiratory Physiology & Neurobiology 152,169-175 

IRB NUMBER: HSC-MS-20-1032 
IRB APPROVAL DATE: 12/03/2020 
22 
 
Hu, H., Li, S., Li, S. (2015) Pain modulation effect of breathing-controlled electrical stimulation 
(BreEStim) is not likely to be mediated by fast and deep voluntary breathing. Scientific Reports 
5,14228 
Huang, C., Wang, Y., Han, J. S., Wan, Y. (2002) Characteristics of electroacupuncture-induced analgesia 
in mice: variation with strain, frequency, intensity and opioid involvement. Brain Res 945,20-25 
Hui, K. K. S., Liu, J., Makris, N., et al. (2000) Acupuncture modulates the limbic system and subcortical 
gray structures of the human brain: Evidence from fMRI studies in normal subjects. Human Brain 
Mapping 9,13 
Iigaya, K., Horiuchi, J., McDowall, L. M., Dampney, R. A. L. (2010) Topographical specificity of 
regulation of respiratory and renal sympathetic activity by the midbrain dorsolateral 
periaqueductal gray. American Journal of Physiology - Regulatory, Integrative and Comparative 
Physiology 299,R853-R861 
Ikeda, E. R., Borg, A., Brown, D., Malouf, J., Showers, K. M., Li, S. (2009) The valsalva maneuver 
revisited: the influence of voluntary breathing on isometric muscle strength. J Strength Cond Res 
23,127-132 
Isnard, J., Magnin, M., Jung, J., Mauguire, F., Garcia-Larrea, L. (2011) Does the insula tell our brain that 
we are in pain? Pain 152,946 
Jensen, J., McIntosh, A. R., Crawley, A. P., Mikulis, D. J., Remington, G., Kapur, S. (2003) Direct 
activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40,1251 
Jensen, M. P., Chodroff, M. J., Dworkin, R. H. (2007) The impact of neuropathic pain on health-related 
quality of life: review and implications. Neurology 68,1178-1182 
Jensen, T. S., Krebs, B., Nielsen, J., Rasmussen, P. (1985) Immediate and long-term phantom limb pain in 
amputees: Incidence, clinical characteristics and relationship to pre-amputation limb pain. Pain 
21,267 
Johnson, M. I., Bjordal, J. M. (2011) Transcutaneous electrical nerve stimulation for the management of 
painful conditions: Focus on neuropathic pain. Expert Review of Neurotherapeutics 11,735 
Jones, S. L., Gebhart, G. F. (1988) Inhibition of spinal nociceptive transmission from the midbrain, pons 
and medulla in the rat: Activation of descending inhibition by morphine, glutamate and electrical 
stimulation. Brain Research 460,281 
Kalra, A., Urban, M. O., Sluka, K. A. (2001) Blockade of opioid receptors in rostral ventral medulla 
prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J 
Pharmacol Exp Ther 298,257-263 
Karri, J., Li, S., Chen, Y. T., Stampas, A., Li, S. (2019) Observations of Autonomic Variability Following 
Central Neuromodulation for Chronic Neuropathic Pain in Spinal Cord Injury. Neuromodulation 
Karri, J., Li, S., Zhang, L., Chen, Y.-T., Stampas, A., Li, S. (2018a) Neuropathic pain modulation after 
spinal cord injury by breathing-controlled electrical stimulation (BreEStim) is associated with 
restoration of autonomic dysfunction. Journal of Pain Research under review 
Karri, J., Li, S., Zhang, L., Chen, Y. T., Stampas, A., Li, S. (2018b) Neuropathic pain modulation after 
spinal cord injury by breathing-controlled electrical stimulation (BreEStim) is associated with 
restoration of autonomic dysfunction. J Pain Res 11,2331-2341 
Katz, J., France, C., Melzack, R. (1989) An association between phantom limb sensations and stump skin 
conductance during transcutaneous electrical nerve stimulation (TENS) applied to the contralateral 
leg: a case study. Pain 36,367-377 
Kooijman, C. M., Dijkstra, P. U., Geertzen, J. H. B., Elzinga, A., van der Schans, C. P. (2000) Phantom 
pain and phantom sensations in upper limb amputees: an epidemiological study. Pain 87,33 
LaBuda, C. J., Fuchs, P. N. (2005) Attenuation of negative pain affect produced by unilateral spinal nerve 
injury in the rat following anterior cingulate cortex activation. Neuroscience 136,311 
LaGraize, S. C., Borzan, J., Peng, Y. B., Fuchs, P. N. (2006) Selective regulation of pain affect following 
activation of the opioid anterior cingulate cortex system. Experimental Neurology 197,22 

23 
 
Lahuerta, J., Buxton, P., Lipton, S., Bowsher, D. (1992) The location and function of respiratory fibres in 
the second cervical spinal cord segment: respiratory dysfunction syndrome after cervical 
cordotomy. J Neurol Neurosurg Psychiatry 55,1142-1145 
Laureys, S. (2007) Eyes open, brain shut. Sci Am 296,84-89 
Li, S. (2013) Breathing-controlled Electrical Stimulation (BreEStim) for management of neuropathic pain 
and spasticity. J Vis Exp,e50077 
Li, S., Berliner, J. C., Melton, D. H., Li, S. (2013) Modification of electrical pain threshold by voluntary 
breathing-controlled electrical stimulation (BreEStim) in healthy subjects. PLoS One 8,e70282 
Li, S., Davis, M., Frontera, J. E., Li, S. (2016) A novel nonpharmacological intervention - breathing- 
controlled electrical stimulation for neuropathic pain management after spinal cord injury - a 
preliminary study. J Pain Res 9,933-940 
Li, S., Hu, T., Beran, M. A., Li, S. (2014) Habituation to Experimentally Induced Electrical Pain during 
Voluntary-Breathing Controlled Electrical Stimulation (BreEStim). PLoS One 9,e104729 
Li, S., Laskin, J. J. (2006) Influences of ventilation on maximal isometric force of the finger flexors. 
Muscle Nerve 34,651-655 
Li, S., Melton, D. H., Berliner, J. C. (2012a) Breathing-controlled electrical stimulation (BreEStim) could 
modify the affective component of neuropathic pain after amputation: a case report. Journal of 
Pain Research 5,71-75 
Li, S., Melton, D. H., Berliner, J. C. (2012b) Breathing-controlled electrical stimulation could modify the 
affective component of neuropathic pain after amputation: a case report. Journal of Pain Research 
5,71 
Li, S., Melton, D. H., Li, S. (2015) Tactile, thermal, and electrical thresholds in patients with without 
phantom limb pain after traumatic lower limb amputation. Journal of Pain Research 8,1-6 
Li, S., Rymer, W. Z. (2011a) Voluntary breathing influences corticospinal excitability of nonrespiratory 
finger muscles. J Neurophysiol 105,512-521 
Li, S., Rymer, W. Z. (2011b) Voluntary breathing influences corticospinal excitability of nonrespiratory 
finger muscles. Journal of neurophysiology 105,512-521 
Li, S., Stampas, A., Frontera, J. E., Davis, M. E., Li, S. (2018) Combined transcranial direct current 
stimulation (tDCS) and breathing controlled electrical stimulation (BreEStim) for management of 
neuropathic pain after spinal cord injury. Journal of Rehabilitation Medicine Under Review 
Li, S., Yasuda, N. (2007) Forced ventilation increases variability of isometric finger forces. Neurosci Lett 
412,243-247 
Lorenz, J., Minoshima, S., Casey, K. L. (2003) Keeping pain out of mind: the role of the dorsolateral 
prefrontal cortex in pain modulation. Brain 126,1079-1091 
Macey, K. E., Macey, P. M., Woo, M. A., Harper, R. K., Alger, J. R., Keens, T. G., Harper, R. M. (2004) 
fMRI signal changes in response to forced expiratory loading in congenital central hypoventilation 
syndrome. J Appl Physiol 97,1897-1907 
Macey, P. M., Macey, K. E., Henderson, L. A., et al. (2003) Functional magnetic resonance imaging 
responses to expiratory loading in obstructive sleep apnea. Respir Physiol Neurobiol 138,275-290 
Makin, T. R., Scholz, J., Filippini, N., Henderson Slater, D., Tracey, I., Johansen-Berg, H. (2013) 
Phantom pain is associated with preserved structure and function in the former hand area. Nature 
Communications 4 
Manchikanti, L., Helm 2nd, S., Fellows, B., Janata, J. W., Pampati, V., Grider, J. S., Boswell, M. V. 
(2012) Opioid epidemic in the United States. Pain physician 15,ES9-38 
Maskill, D., Murphy, K., Mier, A., Owen, M., Guz, A. (1991) Motor cortical representation of the 
diaphragm in man. J Physiol 443,105-121 
Mazzone, S. B., McLennan, L., McGovern, A. E., Egan, G. F., Farrell, M. J. (2007) Representation of 
Capsaicin-evoked Urge-to-Cough in the Human Brain Using Functional Magnetic Resonance 
Imaging. Am. J. Respir. Crit. Care Med. 176,327-332 
McCarthy, M., Jr., Chang, C. H., Pickard, A. S., et al. (2005) Visual analog scalesIRfBorNaUssMeBssEiRn:gHsSuCrg-MicSa-l20-1032 
pain. J Am Coll Surg 201,245-252 
IRB APPROVAL DATE: 12/03/2020 

IRB APPROVAL DATE: 12/03/2020 
24 
 
Melzack, R., Wall, P. D. (1965) Pain mechanisms: a new theory. Science 150,971-979 
Mulvey, M. R., Bagnall, A. M., Johnson, M. I., Marchant, P. R. (2010) Transcutaneous electrical nerve 
stimulation (TENS) for phantom pain and stump pain following amputation in adults. Cochrane 
Database Syst Rev,CD007264 
Murphy, D., Reid, D. B. (2001) Pain treatment satisfaction in spinal cord injury. Spinal Cord 39,44-46 
Nikolajsen, L., Jensen, T. S. (2001) Phantom limb pain. British Journal of Anaesthesia 87,107-116 
Norrbrink Budh, C., Hultling, C., Lundeberg, T. (2005) Quality of sleep in individuals with spinal cord 
injury: a comparison between patients with and without pain. Spinal Cord 43,85-95 
Norrbrink Budh, C., Lundeberg, T. (2004) Non-pharmacological pain-relieving therapies in individuals 
with spinal cord injury: a patient perspective. Complement Ther Med 12,189-197 
Ortiz-Catalan, M., Guðmundsdóttir, R. A., Kristoffersen, M. B., et al. (2016) Phantom motor execution 
facilitated by machine learning and augmented reality as treatment for phantom limb pain: a single 
group, clinical trial in patients with chronic intractable phantom limb pain. The Lancet 388,2885- 
2894 
Peyron, R., Laurent, B., Garcia-Larrea, L. (2000) Functional imaging of brain responses to pain. A review 
and meta-analysis (2000). Neurophysiol Clin 30,263-288 
Plum, F., Leight, R. J. (1981) Abnormalities of central mechanism. In: Hornbeim TF (ed) Regulation of 
Breathing, Part II, Lung Biogy in Health and Disease. Marcel Dekker, New York, pp 989-1067 
Ramsay, S. C., Adams, L., Murphy, K., et al. (1993) Regional cerebral blood flow during volitional 
expiration in man: a comparison with volitional inspiration. J Physiol 461,85-101 
Rennefeld, C., Wiech, K., Schoell, E. D., Lorenz, J., Bingel, U. (2010) Habituation to pain: Further 
support for a central component. Pain 148,503 
Sharshar, T., Hopkinson, N. S., Jonville, S., et al. (2004) Demonstration of a second rapidly conducting 
cortico-diaphragmatic pathway in humans. Journal of Physiology 560,897 
Sherman, R. A., Sherman, C. J., Parker, L. (1984) Chronic phantom and stump pain among American 
veterans: results of a survey. Pain 18,83-95 
Sluka, K. A., Deacon, M., Stibal, A., Strissel, S., Terpstra, A. (1999) Spinal blockade of opioid receptors 
prevents the analgesia produced by TENS in arthritic rats. J Pharmacol Exp Ther 289,840-846 
Sluka, K. A., Walsh, D. (2003) Transcutaneous electrical nerve stimulation: Basic science mechanisms 
and clinical effectiveness. Journal of Pain 4,109 
Smejkal, V., Druga, R., Tintera, J. (1999) Control of breathing and brain activation in human subjects 
seen by functional magnetic resonance imaging. Physiol Res 48,21-25 
Smejkal, V., Druga, R., Tintera, J. (2000) Brain activation during volitional control of breathing. Physiol 
Res 49,659-663 
Stehberg, J., Levy, D., Zangen, A. (2009) Impairment of aversive memory reconsolidation by localized 
intracranial electrical stimulation. Eur J Neurosci 29,964-969 
Stormer, S., Gerner, H. J., Gruninger, W., et al. (1997) Chronic pain/dysaesthesiae in spinal cord injury 
patients: results of a multicentre study. Spinal Cord 35,446-455 
Tracey, I. (2005) Nociceptive processing in the human brain. Curr Opin Neurobiol 15,478-487 
Treede, R. D., Jensen, T. S., Campbell, J. N., et al. (2008) Neuropathic pain: Redefinition and a grading 
system for clinical and research purposes. Neurology 70,1630 
Tsumori, T., Yokota, S., Kishi, T., Qin, Y., Oka, T., Yasui, Y. (2006) Insular cortical and amygdaloid 
fibers are in contact with posterolateral hypothalamic neurons projecting to the nucleus of the 
solitary tract in the rat. Brain Res 1070,139-144 
Valet, M., Sprenger, T., Boecker, H., et al. (2004) Distraction modulates connectivity of the cingulo- 
frontal cortex and the midbrain during pain--an fMRI analysis. Pain 109,399-408 
van Marle, H. J., Hermans, E. J., Qin, S., Fernandez, G. (2010) Enhanced resting-state connectivity of 
amygdala in the immediate aftermath of acute psychological stress. Neuroimage 53,348-354 
Von Baeyer, C. L. (1998) Everyday pain in three- To five-year-old children in day care. Pain Research 
and Management 3,111 
IRB NUMBER: HSC-MS-20-1032 

IRB APPROVAL DATE: 12/03/2020 
25 
 
Von Leupoldt, A., Sommer, T., Kegat, S., et al. (2009) Down-regulation of insular cortex responses to 
dyspnea and pain in asthma. American Journal of Respiratory and Critical Care Medicine 
180,232 
Wall, P. D., Sweet, W. H. (1967) Temporary abolition of pain in man. Science 155,108-109 
Wan, Y., Wilson, S. G., Han, J., Mogil, J. S. (2001) The effect of genotype on sensitivity to 
electroacupuncture analgesia. Pain 91,5-13 
Wartan, S. W., Hamann, W., Wedley, J. R., McColl, I. (1997) Phantom pain and sensation among British 
veteran amputees. British Journal of Anaesthesia 78,652 
Werhagen, L., Budh, C. N., Hultling, C., Molander, C. (2004) Neuropathic pain after traumatic spinal 
cord injury - Relations to gender, spinal level, completeness, and age at the time of injury. Spinal 
Cord 42,665 
Whyte, A. S., Carroll, L. J. (2002) A preliminary examination of the relationship between employment, 
pain and disability in an amputee population. Disability and Rehabilitation 24,462-470 
Willis, W. D., Coggeshall, R. E. (1991) Sensory mechanisms of the spinal cord. Plenum Press, New York 
Woolf, C. J., Mannion, R. J. (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and 
management. The Lancet 353,1959 
Wu, M. T., Sheen, J. M., Chuang, K. H., et al. (2002) Neuronal specificity of acupuncture response: A 
fMRI study with electroacupuncture. NeuroImage 16,1028 
Yoo, S. S., Teh, E. K., Blinder, R. A., Jolesz, F. A. (2004) Modulation of cerebellar activities by 
acupuncture stimulation: Evidence from fMRI study. NeuroImage 22,932 
Ziegler-Graham, K., MacKenzie, E. J., Ephraim, P. L., Travison, T. G., Brookmeyer, R. (2008) 
Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 
89,422-429 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IRB NUMBER: HSC-MS-20-1032